Peer review reports
From: C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study
Original Submission |
3 Apr 2015 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
|
Author responded |
Author comments
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 5 |
|
Submitted |
Manuscript version 5
|
|
Author responded |
Author comments
|
Resubmission - Version 6 |
|
Submitted |
Manuscript version 6
|
|
Author responded |
Author comments
|
Resubmission - Version 7 |
|
Submitted |
Manuscript version 7
|
Publishing |
5 Aug 2015 |
Editorially accepted |
|
14 Aug 2015 |
Article published |
10.1186/s12876-015-0333-z
|
Learn about peer review